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Aspirin inhibits cell growth at high concentrations and stimulates cell growth at low concentrations in 
cultured human aortic vascular smooth muscle cells. Glyceryl trinitrate (GTN) is also found to inhibit 
smooth muscle cell (SMC) growth. From our data using the MTT test (Winn et al., 2004), GTN is a more 
potent inhibitor of SMC growth, but is less effective than aspirin. Hughes et al., (2003) showed that the 
toxicity of naproxen and sulindac in human colorectal cancer cells could be reversed by polyamines. We 
hypothesized that altered intracellular polyamine content could be involved in the mechanism of action of 
aspirin and GTN in SMC growth. To investigate this, primary cultures of pig coronary artery SMC (PCA) 
were used. Polyamine uptake was measured using a modification of the method described by Wallace and 
Mackarel, (1998). Cell cultures were treated with 18.5 kBq [3H]-putrescine/ml medium volume. After 3 
days drug treatment, cells were scraped into 0.2M perchloric acid and incubated on ice for 15 min before 
scintillation counting. At the same time growth was measured by the MTT assay. 
 
 
 
 
 
 
 
Figure 1 shows cell growth expressed as a % of control cell growth measured by MTT test for cells exposed 
to aspirin and GTN. High concentrations of GTN, and to a greater extent aspirin, significantly inhibited cell 
growth. However, low concentrations of aspirin and GTN stimulated cell growth. Table 1 shows an 
increase of polyamine uptake at low concentrations of both drugs in PCAs. At high concentrations of both 
drugs uptake returned to control levels.  Our data shows that the uptake of polyamines increased as cell 
growth was stimulated supporting a link between polyamine concentrations and cell growth. 
Aspirin 
(µM) 
Control 1 50 3000 
Polyamine 
Uptake 
(dpm/mg 
protein) 
90,891 
±7461 
103,726 
±10632 
270,329 
±29848** 
83,963 
±27200 
 
GTN 
(µM) 
Control 3 10 200 
Polyamine 
Uptake 
(dpm/mg- 
protein) 
268,498 
±16434 
463,501 
±27123* 
243,915 
±70630 
177,988 
±43034 
*p <0.005, **p <0.0001 compared with the untreated 
control values (ANOVA followed by Dunnett’s test) 
Table 1 Polyamine uptake for PCAs when incubated 
with aspirin (above) and GTN (below). Results are mean 
± SEM, n=4 
Figure 1 MTT Assay in PCAs after three days drug
treatment with aspirin and GTN. The y-axis shows
% of control cell growth. * p<0.05, compared with
the control values. ANOVA followed by Dunnett’s
test. Results are mean ± SEM, n=10. 
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